Companies
/Healthcare
CVS Health Corp
$80.84
▲ $0.80 (+1.00%) today
Markets closed · 5:09pm ET
CVS Health (CVS) Earnings History & Trends
100%
EPS beat rate
+23.94%
Avg. EPS surprise
Consecutive EPS beats
CVS vs Market · 30-day return after each reportCVSS&P 500
CVS EPS Trend · estimate vs actualEstimateActual
CVS Revenue Trend · estimate vs actualEstimateActual
How Often Does CVS Health Beat Earnings Estimates?
CVS Health beat EPS estimates in 7 of its last 7 reported quarters, and has beaten 7 quarters in a row.
| Quarter | EPS · est. | Surprise | Revenue · est. | Surprise |
|---|---|---|---|---|
| Q3 2026 Adjusted EPS excludes $425 million amortization of intangible assets, a $193 million Omnicare guarantee charge, $13 million acquisition-related integration costs and $(3) million net realized capital gains, net of $(103) million tax impact. GAAP diluted EPS was $1.68. | $2.09 est. $1.65 | +26.61% | $108.4B est. $104.7B | +3.54% |
| Q2 2026 | $2.58 est. $1.85 | +39.36% | $106.1B est. $100.1B | +6.00% |
| Q1 2026 | $2.57 est. $2.21 | +16.29% | $100.4B est. $95.0B | +5.69% |
| Q4 2025 | $1.09 est. $1.00 | +9.00% | $105.7B est. $103.6B | +2.02% |
| Q3 2025 | $1.60 est. $1.36 | +17.65% | $102.9B est. $98.8B | +4.08% |
| Q2 2025 | $1.81 est. $1.46 | +23.97% | $98.9B est. $94.6B | +4.57% |
| Q1 2025 | $2.25 est. $1.67 | +34.73% | $94.6B est. $93.4B | +1.31% |
Figures from SEC filings and company reports. Not investment advice.